Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.50 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12276505 | 1.00 | AKR1C3 (0.64) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL464969 | 1.00 | AKR1C3 (0.64) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5072384 | 0.86 | MAPT (0.50) | AKR1C3ALDH1A1MEN1KMT2AHTT | |
| SCHEMBL5072381 | 0.86 | MAPT (0.50) | AKR1C3ALDH1A1MEN1KMT2AHTT | |
| SCHEMBL28489502 | 0.86 | AKR1C3 (0.67) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17447210 | 0.85 | AKR1C3 (0.60) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27848450 | 0.85 | AKR1C3 (0.60) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27383706 | 0.84 | AKR1C3 (0.64) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL27414529 | 0.84 | AKR1C3 (0.64) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9875130 | 0.84 | AKR1C3 (0.64) | AKR1C3ALDH1A1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072151-A1 | SELECTIVE PARTIAL REDUCTION OF ESTERS USING GROUP IV TRANSITION METAL CATALYSTS AND USES THEREOF | BAYLOR UNIVERSITY (US) | 2025-04-03 | — | — | WO | disclosed |
| US-20250100984-A1 | SELECTIVE PARTIAL REDUCTION OF ESTERS USING GROUP IV TRANSITION METAL CATALYSTS AND USES THEREOF | BAYLOR UNIVERSITY (US) | 2025-03-27 | — | — | US | disclosed |
| CN-117623924-A | Preparation method and application of trisubstituted olefin | 苏州新启材料科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-3654077-B1 | CIRCULAR POLARIZING PLATE | LG CHEMICAL LTD (KR) | 2023-02-22 | — | — | EP | disclosed |
| WO-2022257440-A1 | ENCAPSULATION THIN FILM, ENCAPSULATION STRUCTURE FOR OPTOELECTRONIC DEVICE, AND ENCAPSULATION METHOD | TCL科技集团股份有限公司 | 2022-12-15 | — | — | WO | disclosed |
| CN-110709056-B | Aqueous microemulsion | 弗门尼舍有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-114975086-A | Method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-11411206-B2 | Circularly polarizing plate | LG CHEM, LTD. (KR) | 2022-08-09 | — | — | US | disclosed |
| EP-3654077-A1 | CIRCULAR POLARIZING PLATE | LG Chem, Ltd. (KR) | 2020-05-20 | — | — | EP | disclosed |
| US-20200136094-A1 | CIRCULARLY POLARIZING PLATE | SHANJIN OPTOELECTRONICS (SUZHOU) CO., LTD. (CN) | 2020-04-30 | — | — | US | disclosed |
| US-20100087321-A1 | Azolylmethyloxiranes, their use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them | BASF SE (DE) | 2010-04-08 | — | — | US | disclosed |
| US-20090270256-A1 | Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same | BASF SE (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090203700-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them | BASF SE (DE) | 2009-08-13 | — | — | US | disclosed |
| US-20090197929-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Agents Containing Said Compounds | BASF SE (DE) | 2009-08-06 | — | — | US | disclosed |
| EP-1781617-A4 | ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION | JANSSEN PHARMACEUTICA NV (BE) | 2009-06-24 | — | — | EP | disclosed |
| US-7501510-B2 | Thiourea compositions and uses thereof | THE UNIVERSITY OF HONG KONG (CN) | 2009-03-10 | — | — | US | disclosed |
| EP-1781617-A2 | ALPHA, BETA-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006004742-A2 | α, β-UNSATURATED ESTERS AND ACIDS BY STEREOSELECTIVE DEHYDRATION | JANSSEN PHARAMCEUTICA N.V. (BE) | 2006-01-12 | — | — | WO | disclosed |
| US-20060004195-A1 | Alpha,beta-unsaturated esters and acids by stereoselective dehydration | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-01-05 | — | — | US | disclosed |
| US-3936473-A | COPPER OR NOBLE METAL SALT, OXYGEN AND ORGANIC ACID CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197929-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Agents Containing Said Compounds | CBR3, PPOX, CBR1 | AKR1C3 12/4885ALDH1A1 465/4885NPC1 2438/4885 |
| US-20250100984-A1 | SELECTIVE PARTIAL REDUCTION OF ESTERS USING GROUP IV TRANSITION METAL CATALYSTS AND USES THEREOF | ADH1A, ADH5, ADH1C | AKR1C3 55/4885ALDH1A1 66/4885NPC1 3519/4885 |
| US-20090203700-A1 | Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them | CBR3, NAT1, C5 | AKR1C3 11/4885ALDH1A1 725/4885NPC1 3233/4885 |
| US-20060004195-A1 | Alpha,beta-unsaturated esters and acids by stereoselective dehydration | CCKAR, CCKBR, FFAR1 | AKR1C3 229/4885ALDH1A1 597/4885NPC1 1514/4885 |
| US-20100087321-A1 | Azolylmethyloxiranes, their use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them | PAH, AKR1C4, NAT1 | AKR1C3 5/4885ALDH1A1 960/4885NPC1 2386/4885 |
| US-20090270256-A1 | Azolylmethyloxiranes, Use Thereof for Controlling Plant Pathogenic Fungi, and Agents Containing the Same | NAT1, CBR3, C5 | AKR1C3 10/4885ALDH1A1 600/4885NPC1 2920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.